Efficacy of a Mobile Texting App (HepTalk) in Encouraging Patient Participation in Viral Hepatitis B Care:

Chul Hyun1, Joseph McMenamin2, Okhyun Ko3

  • 1The Center for Viral Hepatitis, Englewood, NJ, United States.

Insights

A mobile texting app called HepTalk effectively connected 95% of Korean American participants with hepatitis B virus (HBV) care, overcoming common healthcare access barriers. This tool improved patient engagement and health care access for HBV-infected individuals.

Area of Science:

  • Hepatology
  • Digital Health
  • Health Disparities

Background:

  • Chronic hepatitis B virus (HBV) infection significantly impacts liver health and mortality in Asian Americans.
  • Access to adequate healthcare for HBV-infected individuals is hindered by numerous barriers.

Purpose of the Study:

  • To evaluate the efficacy of the HepTalk mobile texting app in addressing healthcare access barriers.
  • To improve patient engagement and healthcare access for individuals with HBV infection or those nonimmune to HBV.

Main Methods:

  • The HepTalk app facilitated two-way communication between participants and patient navigators.
  • 82 Korean American participants (HBV-infected or nonimmune) were enrolled from a community campaign.
  • Message frequency and themes were analyzed over a 6-month intervention period to assess linkage to care.

Main Results:

  • Patient navigators exchanged an average of 14 sent and 8 received messages per participant over 6 months.
  • Key message themes included provider identification, appointment scheduling, health education, and financial concerns.
  • A 95% linkage to care rate was achieved, with 78 out of 82 participants connected to healthcare services.

Conclusions:

  • The HepTalk mobile texting app serves as an effective tool for enhancing communication between patients and healthcare providers.
  • This improved communication can significantly boost patient engagement and facilitate access to necessary healthcare services for HBV management.
Abstract